Manufacturer record
NDB Healthcare: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
4 batches manufactured by NDB Healthcare (Himachal Pradesh) were declared Not of Standard Quality between July 2025 and May 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
4 records linked to NDB Healthcare in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Triamcinolone Acetonide Injection IP | NB02I065bMfg 2025-02 · Exp 2027-01 | The sample does not conform to IP with respect to test for SterilitySterility | CDL, KolkataCDSCO lab | May 2026 |
| Triamcinolone Acetonide Injection IP | NB021065bMfg 2025-02 · Exp 2027-01 | SterilitySterility | CDL, KolkataState lab | May 2026 |
| Ambroxol Hydrochloride, Terbutaline Sulphate, Guaiphenesin & Menthol Syrup | NB10L017AMfg 2025-10 · Exp 2027-09 | The sample does not conform to claim as per Patent and Proprietary in respect to the Assay of MentholAssay | RDTL, ChandigarhCDSCO lab | Jan 2026 |
| NEPAFENAC OPHTHALMIC SUSPENSION (ELNEP EYE DROPS) | NE12B028Mfg 2024-12 · Exp 2026-11 | Incorrect labellingLabelling | DTL, PuducherryState lab | Jul 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.